Skip to content
OpenCapital
Get started

First Tracks Biotherapeutics, Inc. Ordinary Shares TRAX Income Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
Q1 '26
Research and development
$33.96M-18.1%
General and administrative
$18.86M+92.1%
Total operating expenses
$52.81M+3.0%
Operating income
-$52.81M-3.0%
Other income (expense), net
$2.33M-43.0%
Net income
-$50.48M-7.0%
EBITDA
-$52.69M-3.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does First Tracks Biotherapeutics, Inc. Ordinary Shares's income statement data come from?
Every line is extracted from First Tracks Biotherapeutics, Inc. Ordinary Shares's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.